Rigel Pharmaceuticals RIGL Operating Lease Liability Payments - 2026 (Lessee)
Operating Lease Liability Payments - 2026 (Lessee) at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo.
The official record: Rigel Pharmaceuticals’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's operating lease liability payments - 2026 (lessee).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Rigel Pharmaceuticals's operating lease liability payments - 2026 (lessee)?
- Rigel Pharmaceuticals (RIGL) reported operating lease liability payments - 2026 (lessee) of $409K in Q4 2025.
- What does operating lease liability payments - 2026 (lessee) mean?
- This represents the specific cash outflow commitment for operating leases scheduled for the calendar year 2026. It allows investors to isolate the impact of real estate and equipment lease obligations on the company's cash flow in a specific future period.